MARCH1 expression was significantly upregulated in breast cancer (BRCA), cervical squamous cell carcinomas (CESC), cholangiocarcinoma (CHOL), esophageal carcinoma (ESCA), head and neck squamous cell carcinoma (HNSC), kidney chromophobe (KICH), kidney renal clear cell carcinoma (KIRC), kidney renal papillary cell carcinoma (KIRP), and stomach adenocarcinoma (STAD). Here, MARCHF1 is linked to invasive breast carcinoma.